Digital Health: Page 29


  • Warren, Murray, Smith redouble scrutiny of FDA over Pre-Cert safety, authority

    FDA maintains it has the statutory authority to conduct the software Pre-Cert pilot, but acknowledged it will need help from Congress to update what it calls a 40-year-old regulatory paradigm for 21st century technologies.

    By David Lim • Oct. 31, 2019
  • Image attribution tooltip
    Livongo
    Image attribution tooltip

    Livongo inks pacts with Doctor on Demand, MDLive

    The digital chronic disease management company will offer telehealth services to its behavioral health members beginning in 2020, with plans to extend the option to users of its diabetes and hypertension platforms shortly thereafter.​​

    By Linda Wilson • Oct. 29, 2019
  • Sleep apnea testing shifts to the home, survey suggests

    Use of home-based testing has more than doubled in the past five years as more sleep centers offer the option, which analysts expect will benefit ResMed.

    By Oct. 21, 2019
  • Image attribution tooltip
    Novartis
    Image attribution tooltip

    Novartis takes step back from marketing Pear prescription digital therapeutics

    While Sandoz and Pear Therapeutics are still working together, the Swiss pharma unit will no longer co-promote the recently launched substance and opioid abuse treatments.

    By Kristin Jensen • Oct. 17, 2019
  • Fitbit, Bristol-Myers, Pfizer partner to speed earlier diagnosis of AFib

    The two drugmakers sell Eliquis, an anticoagulant for stroke prevention in individuals with atrial fibrillation, which reached nearly $4 billion in sales over the first six months of 2019. 

    By David Lim • Oct. 17, 2019
  • Smartphone health coaching gets some people moving, study says

    The Stanford-backed research looked at e-coaching programs that successfully prompted users to increase daily steps. Limitations included a high dropout rate and demographics not representative of the general U.S. population.

    By Oct. 14, 2019
  • Abbott deepens Type 2 diabetes play with Omada partnership

    While CGMs have been most widely adopted among the Type 1 population, Abbott has worked to show the technology's benefit in the under-penetrated Type 2 market, which accounts for 95% of all Americans living with diabetes.​

    By Maria Rachal • Oct. 14, 2019
  • Amazon Textract now HIPAA-eligible as tech giant expands AI portfolio

    Of Amazon's $3.1 billion in operating income last quarter, more than half came from its cloud services business. 

    By Rebecca Pifer • Oct. 11, 2019
  • Image attribution tooltip
    Brian Tucker / MedTech Dive
    Image attribution tooltip
    Q&A

    Medtech investor duo seeks to 'fill the gap' in device sector private funding

    As big medtechs turn toward smaller players to fuel their pipelines, Justin Klein and Kirk Nielsen, managing partners of newly formed Vensana Capital, are looking to build out a $225 million portfolio in "a really undercapitalized sector."

    By Maria Rachal • Oct. 8, 2019
  • Image attribution tooltip
    Livongo
    Image attribution tooltip

    Livongo scores biggest diabetes contract yet

    Investors reacted to the news of the BCBS federal employee program agreement by bumping up Livongo's shares more than 18%. 

    By Oct. 8, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AI clinical support opens physicians to potential liabilities: JAMA

    Legal considerations for doctors using clinical decision support software come amid challenges for regulators attempting to define a framework to oversee the emerging technologies.

    By David Lim • Oct. 7, 2019
  • IMDRF cybersecurity guidance favors total product life cycle approach

    The International Medical Device Regulators Forum's draft mirrors U.S. regulators' support for a total product life cycle strategy, but does not include a tiered approach to categorizing risk laid out by FDA last year.

    By Oct. 3, 2019
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Venture capital investing in digital health cools in Q3: report

    A quarterly update from Rock Health said funding for digital health remains near all-time highs but is slowing. A new analysis from Ropes & Gray found startups are increasingly partnering with established life sciences companies.

    By Oct. 2, 2019
  • Image attribution tooltip
    Duke University
    Image attribution tooltip

    Alphabet hires ex-FDA commissioner to lead health strategy, policy

    The company's acquisition of Robert Califf comes roughly a year after its subsidiary Google hired ex-Geisinger CEO David Feinberg to lead health strategy.

    By Rebecca Pifer • Oct. 1, 2019
  • Image attribution tooltip
    Fitbit
    Image attribution tooltip
    Q&A

    Disruption or integration? Fitbit's health leader on the role of wearables in healthcare

    Healthcare Dive spoke with Amy McDonough, general manager and SVP of Fitbit Health Solutions, about the wearables giant's competitors, its Premium offering, and how it's always been a healthcare company at the core.

    By Rebecca Pifer • Oct. 1, 2019
  • FDA revises clinical decision support software draft after industry blowback

    The decision to revise the draft guidance comes after feedback on the 2017 version asked the agency to reconsider its approach, Bakul Patel, FDA's director for digital health, told MedTech Dive.

    By David Lim • Sept. 26, 2019
  • To pitch Pre-Cert to Congress, FDA builds a case first

    Enforcement mechanisms and the decision of how the experimental pathway will fit into the current 510(k), De Novo and PMA routes are among the details lawmakers will need to eventually address, an agency official said.

    By Kim Dixon • Sept. 25, 2019
  • Medtechs keep shareholders happy, potentially at pipeline's expense: EY

    The industry recorded its highest revenues ever within the last year, an analysis by the consultancy shows. Even as R&D spending grew 11%, those investments fell short of the proportion of cash returned to investors.

    By Maria Rachal • Sept. 23, 2019
  • FDA creates agencywide tech modernization roadmap

    The agency plans to spend the next one to two years upgrading its infrastructure to meet emerging data handling needs.

    By Sept. 19, 2019
  • Varian buys software developer for AI cancer work

    The radiation oncology company is making an undisclosed investment in privately held Oncora Medical to collaborate on development of machine learning-based software.

    By Sept. 16, 2019
  • FDA clears GE's AI-powered x-ray algorithms for triaging collapsed lungs

    GE Healthcare said the technology will help hospitals identify high-priority cases and fast track treatment.

    By Sept. 13, 2019
  • Apple to start trio of research studies on hearing, heart and women's health

    The studies, which will be organized through a new Apple Research app this fall, are being conducted in partnership with various universities, hospitals, associations and the U.S. government.

    By David Lim • Sept. 11, 2019
  • FDA looks to define 'triggers' for medical device cybersecurity warnings

    When do the benefits of notifying patients of potential risks outweigh possible harms? The agency's Patient Engagement Advisory Committee is weighing in Tuesday.

    By Maria Rachal • Sept. 10, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    With partner iRhythm, Verily ramps up AFib efforts

    iRhythm committed almost $18 million to Verily to boost development of technology that helps deliver earlier warnings to individuals with asymptomatic or silent atrial fibrillation.

    By Maria Rachal • Sept. 5, 2019
  • Fitbit to wade into care management in pilot this year

    The fitness tracker giant also announced it is launching a premium service and plans to develop wellness reports allowing users to share their data with their physician.

    By Rebecca Pifer • Aug. 28, 2019